The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids

Fertility and Sterility

Volumn 87, Issue 5, 2007, Pages 1116-1121

  Gomes, Mariano Tamura Vieira ^a   Castro, Rodrigo de Aquino ^a   Villanova, Fabiola Elizabeth ^a   da Silva, Ismael Dale Cotrim Guerreiro ^a   Baracat, Edmund Chada ^a   de Lima, Geraldo Rodrigues ^a   Girão, Manoel João Batista Castello ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

polymorphism; progesterone receptor; PROGINS; risk factors; sexual steroids receptors; Uterine fibroids; uterine leiomyoma

Indexed keywords

DNA; PROGESTERONE RECEPTOR;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GYNECOLOGY; HUMAN; HUMAN TISSUE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NEGRO; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TEACHING HOSPITAL; UTERUS; UTERUS MYOMA;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 34247497261     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.099     Document Type: Article

References (28)

1. Marshall L.M., Spiegelman D., Barbieri R.L., Goldman M.B., Manson J.E., Colditz G.A., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90 (1997) 967-973
2. Kjerulff K.H., Guzinski G.M., and Langenberg P.W. Hysterectomy and race. Obstet Gynecol 82 (1993) 757-764
3. Vikhlyaeva E.M., Khodzhaeva Z.S., and Fantschenko N.D. Familial predisposition to uterine leiomyomas. Int J Gynecol Obstet 51 (1995) 127-131
4. Rein M.S., Barbieri R.L., and Friedman A.J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172 (1995) 14-18
5. Rein M.S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 108 Suppl 5 (2000) 791-793
6. Rousseau-Merk M.F., Mirashi M., Loosfelt H., Milgrom E., and Berger R. Localization of the human progesterone receptor gene to chromosome 11q22-23. Hum Genet 77 (1987) 280-282
7. Vegeto E., Allan G.F., Schrader W.T., Tsai M.-J., McDonnell D.P., and O'Malley B.W. The mechanism of RU 486 antagonism is dependent upon the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69 (1992) 703-713
8. McKenna N.J., Kieback D.G., Carney D.N., Fanning M., McLinden J., and Headon D.R. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br J Cancer 71 (1995) 451-455
9. Wieser F., Scheneeberger C., Tong D., Tempfer C., Huber J.C., and Wenzi R. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril 77 (2002) 309-312
10. Donaldson C.J., Crapanzano J.P., Watson J.C., Levine E.A., and Batzer M.A. PROGINS Alu insertion and human genomic diversity. Mutat Res 501 (2002) 137-141
11. Parra F.C., Amado R.C., Lambertucci J.R., Rocha J., Antunes C.M., and Pena S.D.J. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100 (2003) 177-182
12. Gattas G.J.F., and Soares-Vieira J.A. Cytochrome P450-2E1 and glutathione S transferase polymorphisms among caucasians mulattoes from Brazil. Occup Med 50 (2000) 508-511
13. Lancaster J.M., Berchuck A., Carney M.E., Wiseman R., and Taylor J.A. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer 71 (1995) 341-345
14. Rowe S.M., Coughlan S.J., McKenna N.J., Garret E., Kieback D.G., Carney D.N., et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 55 (1995) 2743-2745
15. Nussbaum R.L., McInnes R.R., and Willard H.F. Thompson & Thompson genetics in medicine. 6th rev. ed. (2001), WB Saunders, Philadelphia 83-95
16. Hsieh Y.Y., Chan I.P., Wang H.I., Chang C.C., Huang C.W., and Lin C.S. PROGINS Alu sequence insertion is associated with hyperprolactinaemia but not leiomyoma susceptibility. Clin Endocrinol 62 (2005) 492-497
17. Fabjani G., Tong D., Czerwenka K., Schuster E., Speiser P., Leodolter S., et al. Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Res Treat 72 (2002) 131-137
18. Kastner P., Krust A., and Turcotte B. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9 (1990) 1603-1614
19. Vegeto E., Shahbaz M.M., and Wen D.X. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7 (1993) 1244-1255
20. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor form A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85 (2000) 2897-2902
21. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., and Coneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289 (2000) 1751-1754
22. Rein M.S., Friedman A.J., Barbieri R.L., Pavelka K., Fletcher J.A., and Morton C.C. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 77 (1991) 923-926
23. Mantovani M.S., Neto J.B., Philbert P.M., and Casartelli C. Multiple uterine leiomyomas: cytogenetics analysis. Gynecol Oncol 72 (1999) 71-75
24. Marshal R.D., Fejzo M.L.S., Friedman A.J., Mitchner N., Nowak R.A., Rein M.S., et al. Analysis of androgen receptor DNA reveals the independent clonal origin of uterine leiomyoma and secondary nature of cytogenetic aberrations in the development of leiomyomata. Gen Chrom Cancer 11 (1994) 1-6
25. Gloudemans T., Pospiech I., Van Der Ven L.T.M., Lips C.J.M., Den Otter W., and Sussenbach J.S. An AvaII restriction fragment length polymorphism in the insulin-like growth factor II gene and the occurrence of smooth muscle tumors. Cancer Res 53 (1993) 5754-5758
26. Patrikis M.I., Bryan E.J., Thomas N.A., Rice G.E., Quinn M.A., Baker M.S., et al. Mutation analysis of the CDP, TP53, and KRAS in uterine leiomyomas. Mol Carciong 37 (2003) 61-64
27. Al-Hendy A., and Salama A.S. Catechol-O-Methyltransferase polymorphism is associated with increased uterine leiomyoma risk in defferent ethnic groups. J Soc Gynecol Investig 13 (2006) 136-144
28. Massart F., Becherini L., Marini F., Noci I., Piciocchi L., Del Monte F., et al. Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit 9 (2003) BR25-BR30